“This is quite exciting,” said Dr. Shirish M. Gadgeel, a medical oncologist at the Henry Ford Cancer Institute in Detroit.

The number of clinical trials of new drugs in Russia is steadily declining, which could be mainly related with the overall ...

Crypto billionaire Christian Angermayer relocates to Lugano, Switzerland, in response to the UK's new tax regime, ...

DURHAM, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract ...

Thermo Fisher Scientific expands oral solid dose development and manufacturing capabilities across North America: Waltham, Massachusetts Monday, September 30, 2024, 17:00 Hrs [IST ...

(Yicai) Sept. 30 -- AstraZeneca will strengthen its commitment to researching chronic and rare diseases in China, driving ...

The inspection, which took place between September 23 and September 27, 2024, concluded with 4 observations from the ...

We recently published a list of 10 Best Italian Stocks To Buy Now. In this article, we are going to take a look at where ...

INmune Bio's initial results from cohort 1 of the phase I/II CaRe PC trial, using INKmune for the treatment of patients with ...

Healthcare players across emerging fields, from pharmaceuticals to biotech and healthtech, are driving innovation to ...

A public offering of shares prompted a huge insider purchase last week. A couple of repeat buyers further boosted their ...

His journey is marked by a series of impactful roles where his leadership, technical skills, and dedication to excellence ...